Arctx Medical Revenue

About Arctx Medical

About Arctx Cool Catheter therapy The proprietary Arctx Cool Catheter Kit technology was initially developed and tested at Mayo Clinic. Through an exclusive license and further development by Arctx Medical, the Arctx Cool Catheter is designed to reduce the temperature of the inflamed pancreas from within the stomach. Cold water is circulated within the catheter in a closed circuit, which is designed to cool the stomach wall and its contents, and by extension, the immediately adjacent pancreas. Nasogastric placement of the catheter does not require anesthesia, and the therapy is intended to cool the pancreas without inducing patient hypothermia. Arctx is separately seeking FDA 510(k) market authorization for the Arctx Cool Catheter Kit for a body temperature management indication. About Arctx Medical Headquartered in Raleigh NC, privately held Arctx Medical, Inc. has been pioneering the development of treatments for Acute Pancreatitis since 2021. Its mission is to reduce patient illness and pain, speed patient recovery, reduce hospital stays, and decrease health care costs associated with AP. The Arctx Medical Advisory Board, which guides therapy and clinical development, is led by world-renowned gastroenterologist and pancreatic specialist Walter Park, MD at Stanford University. The Company’s investors include Solas BioVentures, Mayo Clinic Ventures, and Scientific Health Development Partners.

View contact profiles from Arctx Medical